Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Serial measurement of presepsin, procalcitonin, and C-reactive protein in the early postoperative period and the response to antithymocyte globulin administration after heart transplantation

J. Franeková, P. Sečník, P. Lavríková, Z. Kubíček, L. Hošková, E. Kieslichová, A. Jabor,

. 2017 ; 31 (1) : . [pub] 20161209

Language English Country Denmark

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc18010937

Differentiation between systemic inflammatory response syndrome and sepsis in surgical patients is of crucial significance. Procalcitonin (PCT) and C-reactive protein (CRP) are widely used biomarkers, but PCT becomes compromised after antithymocyte globulin (ATG) administration, and CRP exhibits limited specificity. Presepsin has been suggested as an alternative biomarker of sepsis. This study aimed to demonstrate the role of presepsin in patients after heart transplantation (HTx). Plasma presepsin, PCT, and CRP were measured in 107 patients serially for up to 10 days following HTx. Time responses of biomarkers were evaluated for both noninfected (n=91) and infected (n=16) patients. Areas under the concentration curve differed in the two groups of patients for presepsin (P<.001), PCT (P<.005), and CRP (P<.001). The effect of time and infection was significant for all three biomarkers (P<.05 all). In contrast to PCT, presepsin was not influenced by ATG administration. More than 25% of noninfected patients had PCT above 42 μg/L on the first day, and the peak concentration of CRP in infected patients was reached on the third post-transplant day (median 135 mg/L). Presepsin seems to be as valuable a biomarker as PCT or CRP in the evaluation of infectious complications in patients after HTx.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18010937
003      
CZ-PrNML
005      
20180605105816.0
007      
ta
008      
180404s2017 dk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/ctr.12870 $2 doi
035    __
$a (PubMed)27859613
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a dk
100    1_
$a Franeková, Janka $u Department of Laboratory Methods, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. Third Faculty of Medicine, Charles University, Prague, Czech Republic.
245    10
$a Serial measurement of presepsin, procalcitonin, and C-reactive protein in the early postoperative period and the response to antithymocyte globulin administration after heart transplantation / $c J. Franeková, P. Sečník, P. Lavríková, Z. Kubíček, L. Hošková, E. Kieslichová, A. Jabor,
520    9_
$a Differentiation between systemic inflammatory response syndrome and sepsis in surgical patients is of crucial significance. Procalcitonin (PCT) and C-reactive protein (CRP) are widely used biomarkers, but PCT becomes compromised after antithymocyte globulin (ATG) administration, and CRP exhibits limited specificity. Presepsin has been suggested as an alternative biomarker of sepsis. This study aimed to demonstrate the role of presepsin in patients after heart transplantation (HTx). Plasma presepsin, PCT, and CRP were measured in 107 patients serially for up to 10 days following HTx. Time responses of biomarkers were evaluated for both noninfected (n=91) and infected (n=16) patients. Areas under the concentration curve differed in the two groups of patients for presepsin (P<.001), PCT (P<.005), and CRP (P<.001). The effect of time and infection was significant for all three biomarkers (P<.05 all). In contrast to PCT, presepsin was not influenced by ATG administration. More than 25% of noninfected patients had PCT above 42 μg/L on the first day, and the peak concentration of CRP in infected patients was reached on the third post-transplant day (median 135 mg/L). Presepsin seems to be as valuable a biomarker as PCT or CRP in the evaluation of infectious complications in patients after HTx.
650    _2
$a dospělí $7 D000328
650    _2
$a antilymfocytární sérum $x aplikace a dávkování $7 D000961
650    _2
$a biologické markery $x metabolismus $7 D015415
650    _2
$a C-reaktivní protein $x metabolismus $7 D002097
650    _2
$a kalcitonin $x metabolismus $7 D002116
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a infekční nemoci $x farmakoterapie $x etiologie $x metabolismus $7 D003141
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a následné studie $7 D005500
650    _2
$a přežívání štěpu $x účinky léků $7 D006085
650    _2
$a transplantace srdce $x škodlivé účinky $7 D016027
650    _2
$a lidé $7 D006801
650    _2
$a imunosupresiva $x aplikace a dávkování $7 D007166
650    _2
$a lipopolysacharidové receptory $x metabolismus $7 D018950
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a peptidové fragmenty $x metabolismus $7 D010446
650    _2
$a pooperační komplikace $x farmakoterapie $x etiologie $x metabolismus $7 D011183
650    _2
$a prognóza $7 D011379
650    _2
$a rizikové faktory $7 D012307
655    _2
$a časopisecké články $7 D016428
700    1_
$a Sečník, Peter $u Department of Laboratory Methods, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. Third Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Lavríková, Petra $u Department of Laboratory Methods, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. Third Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Kubíček, Zdenek $u Department of Laboratory Methods, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. $7 jo2015865150
700    1_
$a Hošková, Lenka $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Kieslichová, Eva $u Department of Anesthesiology, Resuscitation, and Intensive Care, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Jabor, Antonín $u Department of Laboratory Methods, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. Third Faculty of Medicine, Charles University, Prague, Czech Republic.
773    0_
$w MED00001167 $t Clinical transplantation $x 1399-0012 $g Roč. 31, č. 1 (2017)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27859613 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180404 $b ABA008
991    __
$a 20180605110018 $b ABA008
999    __
$a ok $b bmc $g 1288422 $s 1007749
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 31 $c 1 $e 20161209 $i 1399-0012 $m Clinical transplantation $n Clin Transplant $x MED00001167
LZP    __
$a Pubmed-20180404

Find record

Citation metrics

Archiving options